$PL

Raymond John w sold $170K of PL (indirect holdings)

Raymond John w sold 6,494 indirectly-held shares of Planet Labs PBC (PL) at $26.16 ($0.17M total) on 2026-07-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Raymond John w
Published Jul 14, 2026, 9:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 14, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PL
Neutral
high confidence
Mentioned
$PL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price ($26.1582), and post-transaction holdings (37,114 shares), under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for clustering of insider sales, but this single planned sale is unlikely to drive a material repricing.

03

What to watch

The transaction is indirect and under a 10b5-1 plan; without additional context (other sales, option exercises, or changes in holdings), it is hard to infer directionality.

Relevance 3/10Novelty 3/10Timing: Filed on 2026-07-14, covering a sale executed on 2026-07-13.

Background

The article is an SEC Form 4 insider transaction disclosure for Planet Labs PBC, reported by director Raymond John W.

Company-level read

Ticker impact

$PLNeutralHigh confidence
Context

Raymond John W, a Planet Labs director, sold 6,494 shares in an open-market transaction under a 10b5-1 plan, worth about $169.9K.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and small versus normal trading volume.

Evidence & confidence

The filing is an SEC Form 4 insider transaction with a pre-arranged 10b5-1 plan, and the disclosed value ($169.9K) is modest relative to typical market moves.

Market effects

No clear sector read-through; this is company-specific insider trading with no operational or guidance content.

None indicated.

None indicated.

Counterpoint

Even planned 10b5-1 sales can coincide with private views on valuation or liquidity needs, so some traders may treat it as mild bearish sentiment.

Key entities

  • Planet Labs PBC

    Subject of the Form 4 insider transaction disclosure.

  • Raymond John W

    Director who sold shares via an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SPCXMed

SPCX Stock Outperforms Space Peers This Week As RKLB, ASTS, RDW And PL Slide

SpaceX (SPCX) gained 1% this week, while peers like Redwire (RDW), Rocket Lab (RKLB), AST SpaceMobile (ASTS), and Planet Labs (PL) declined. SpaceX acquired Grain Management's spectrum for $8B, pending FCC approval, and secured a deal with American Airlines for Starlink. Up to 328.4M SPCX shares may become eligible for sale on Friday. Other companies reported mixed operational updates and market sentiment.

$PLHigh

Effective Satellite Investment Amid High Multiples for Launch Peers – SatNews

Planet Labs PBC is highlighted as a lower-multiple investment in the commercial space sector, trading at 14.6x price-to-sales, compared to 96x for SpaceX and 55x for Rocket Lab. It reported Q2 revenue of $116.1M, up 58% YoY, with a 57% gross margin and positive free cash flow. Defense revenue surged over 90% YoY, but shares are down 18.15% YTD. Analysts rate it a 'Strong Buy' with a $34.78 target, implying 99% upside.